{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/49203"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/49203","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Characterization of fibrin-targeted microbubbles for detection of peritoneal adhesions","abstract":"There is currently no solution for imaging fibrin-rich adhesions following surgery, yet the condition costs healthcare providers upwards of $2 billion annually. Over the past decade the development of ultrasound contrast agents has seen an increase in commercialization of generic microbubble formulations for standard diagnostic applications such as echocardiography. To enhance diagnostic power, molecularly targeted microbubbles are formulated with the addition of a ligand to the outer shell. The microbubble formulation must be modified so that the contrast agents are stable over time and targeted with the appropriate ligand while maintaining their echogenicity relative to surrounding soft tissue. We used a dual approach to look at microbubbles optically to predict their relative signal enhancement in vivo given their size distribution and concentration. An ImageJ macro script was developed based off BubblesizerJ, a previously developed open-source program. To confirm that modified microbubbles maintain acoustic properties relative to soft tissue, an agarose phantom model was developed that allows for high throughput testing of multiple microbubble formulations.","abstract_html":"There is currently no solution for imaging fibrin-rich adhesions following surgery, yet the condition costs healthcare providers upwards of $2 billion annually. Over the past decade the development of ultrasound contrast agents has seen an increase in commercialization of generic microbubble formulations for standard diagnostic applications such as echocardiography. To enhance diagnostic power, molecularly targeted microbubbles are formulated with the addition of a ligand to the outer shell. The microbubble formulation must be modified so that the contrast agents are stable over time and targeted with the appropriate ligand while maintaining their echogenicity relative to surrounding soft tissue. We used a dual approach to look at microbubbles optically to predict their relative signal enhancement in vivo given their size distribution and concentration. An ImageJ macro script was developed based off BubblesizerJ, a previously developed open-source program. To confirm that modified microbubbles maintain acoustic properties relative to soft tissue, an agarose phantom model was developed that allows for high throughput testing of multiple microbubble formulations.","abstract_has_math":false,"creators":["Harpster, Savannah Lee"],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Biomedical Engineering","degree_department":null,"school":null,"contributors":[],"advisors":["Mertz, Jerome C.","Wong, Joyce Y."],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024","date_published":"2024","updated_at":"2026-11-19T02:41:58Z","subjects":["Biomedical engineering","Adhesions","Contrast agent","Fibrin","Medical ultrasound","Microbubbles","Theranostics"],"languages":["en_US"],"rights":["Attribution-NoDerivatives 4.0 International"],"rights_urls":["http://creativecommons.org/licenses/by-nd/4.0/"],"identifier_entries":[],"person_identifier_entries":[{"key":"dc:identifier.orcid","label":"ORCID","values":["0009-0009-3974-1774"],"render_values":[{"text":"0009-0009-3974-1774","href":"https://orcid.org/0009-0009-3974-1774","code":true}]}]},"links":{"outbound_url":"https://hdl.handle.net/2144/49203","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/49203","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F49203","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Mertz, Jerome C.","Wong, Joyce Y."]},{"key":"dc:creator","label":"Author","values":["Harpster, Savannah Lee"]},{"key":"dc:identifier.orcid","label":"ORCID","values":["0009-0009-3974-1774"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2024-09-04T15:09:18Z"]},{"key":"dc:date.embargo","label":"Dc Date Embargo","values":["2026-09-03T00:00:00Z"]},{"key":"dc:date.issued","label":"Date","values":["2024"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2024-09-03T22:12:51Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biomedical Engineering"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biomedical engineering","Adhesions","Contrast agent","Fibrin","Medical ultrasound","Microbubbles","Theranostics"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]},{"key":"dc:rights","label":"Dc Rights","values":["Attribution-NoDerivatives 4.0 International"]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://creativecommons.org/licenses/by-nd/4.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/49203"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["There is currently no solution for imaging fibrin-rich adhesions following surgery, yet the condition costs healthcare providers upwards of $2 billion annually. Over the past decade the development of ultrasound contrast agents has seen an increase in commercialization of generic microbubble formulations for standard diagnostic applications such as echocardiography. To enhance diagnostic power, molecularly targeted microbubbles are formulated with the addition of a ligand to the outer shell. The microbubble formulation must be modified so that the contrast agents are stable over time and targeted with the appropriate ligand while maintaining their echogenicity relative to surrounding soft tissue. We used a dual approach to look at microbubbles optically to predict their relative signal enhancement in vivo given their size distribution and concentration. An ImageJ macro script was developed based off BubblesizerJ, a previously developed open-source program. To confirm that modified microbubbles maintain acoustic properties relative to soft tissue, an agarose phantom model was developed that allows for high throughput testing of multiple microbubble formulations."]},{"key":"dc:title","label":"Title","values":["Characterization of fibrin-targeted microbubbles for detection of peritoneal adhesions"]}]}],"canonical_facts":{"dc:contributor.advisor":["Mertz, Jerome C.","Wong, Joyce Y."],"dc:creator":["Harpster, Savannah Lee"],"dc:date.accessioned":["2024-09-04T15:09:18Z"],"dc:date.embargo":["2026-09-03T00:00:00Z"],"dc:date.issued":["2024"],"dc:date.updated":["2024-09-03T22:12:51Z"],"dc:description.abstract":["There is currently no solution for imaging fibrin-rich adhesions following surgery, yet the condition costs healthcare providers upwards of $2 billion annually. Over the past decade the development of ultrasound contrast agents has seen an increase in commercialization of generic microbubble formulations for standard diagnostic applications such as echocardiography. To enhance diagnostic power, molecularly targeted microbubbles are formulated with the addition of a ligand to the outer shell. The microbubble formulation must be modified so that the contrast agents are stable over time and targeted with the appropriate ligand while maintaining their echogenicity relative to surrounding soft tissue. We used a dual approach to look at microbubbles optically to predict their relative signal enhancement in vivo given their size distribution and concentration. An ImageJ macro script was developed based off BubblesizerJ, a previously developed open-source program. To confirm that modified microbubbles maintain acoustic properties relative to soft tissue, an agarose phantom model was developed that allows for high throughput testing of multiple microbubble formulations."],"dc:identifier.orcid":["0009-0009-3974-1774"],"dc:identifier.uri":["https://hdl.handle.net/2144/49203"],"dc:language.iso":["en_US"],"dc:rights":["Attribution-NoDerivatives 4.0 International"],"dc:rights.uri":["http://creativecommons.org/licenses/by-nd/4.0/"],"dc:subject":["Biomedical engineering","Adhesions","Contrast agent","Fibrin","Medical ultrasound","Microbubbles","Theranostics"],"dc:title":["Characterization of fibrin-targeted microbubbles for detection of peritoneal adhesions"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Biomedical Engineering"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-19T02:41:58Z"}